Azacbuzz 100 mg Injection for Myelodysplastic Syndromes (MDS)

Azacbuzz 100 mg injection, offered by Chawla Medicos, is used to treat patients with myelodysplastic syndromes (MDS), a group of disorders where bone marrow produces abnormal or insufficient blood cells. Azacitidine, the active ingredient, works by targeting the abnormal cells and encouraging the production of healthy ones. This treatment helps to lower the need for blood transfusions, manage symptoms like fatigue, and improve the quality of life for patients suffering from MDS.

1. — — . E
| Foz E ER Jasgur

Azacitidine for Azacitidine for
| Injection 1.P. 100 mg: „Injection I.P. 100 mg

| AZACBUZZ100 | 4) AZACBUZZ100

BUN"

100mg ¿Vial
| Lyophilized Powder Lyophilized Powder

2. Composition:

Each vial contains

Azacitiding IP 100mg
Mannitol LF a

{As sterile freeze-dried powder for
reconstitution)
SE ere

Keep out of each of children.

COTON AGENT DE,
GOT ne Cr st
and age
pete ee Meet spezistent

prescription

‘CAUTION: itis dangerous to take this
preparation except under medical
Supervision ofa Cancer Specialist.

Mfg. Lic. No. : MB/09/793

we gran

Core a

bao: 05/2096
427500

Maximum
retail pela €;
Inclusive of al tana.

te by E
{esque
JASGUR LIFE SCIENCES LLP
‘Second Foot, Offlos Mo. 02,
Por, Pet No 37, Bleck,
Sete dt Na a

Azacitidine for

Injection I.P. 100 mg

AZACBUZZ-100

100mg / Vial
Lyophilized Powder

ERTL ET

3. FE EN fau:

Azacitidine for Azacitidine for
Injection |.P. 100 mg Injection 1.P 100 mg

AZACBUZZ-100 AZACBUZZ-100

100mg / Vial 100mg / Vial
Lyophilized Powder Lyophilized Powder

4. sn ú ree fra

Azacitidine for = Azacitidine for
Injection 1.P. 100 mg Injection L.P. 100 mg
3 AZACBUZZ100

|
| AZACBUZZ-100

100mg / Vial

100mg / Vial
‘Lyophilized Powder

vorge

5. = 5
_ 7

= Azacitidine for

Injection 1.P. 100 mg
= AZACBUZZ-100
Injection À m H | 100mg / Vial